ストックスクリーナーアプリを入手
23.30
0.43%
-0.0464
前日終値:
$23.35
開ける：
$23.21
24時間の取引高:
211.96K
Relative Volume:
0.35
時価総額：
$1.16B
収益：
$723.55M
当期純損益:
$157.72M
株価収益率:
7.7679
EPS:
3
ネットキャッシュフロー:
$170.15M
1週間 パフォーマンス:
-4.79%
1か月 パフォーマンス:
-17.82%
6か月 パフォーマンス:
-54.25%
1年 パフォーマンス:
-41.89%
1日の値動き範囲:
$22.84
$23.47
1週間の範囲:
$22.64
$24.92
52週間の値動き範囲:
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
名前
Amphastar Pharmaceuticals Inc
セクター
電話
909-980-9484
住所
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.31 | 1.16B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
145.58 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.12 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.83 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.30 | 15.64B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
282.43 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 開始されました | Wells Fargo | Equal Weight |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2023-11-17 | 開始されました | BofA Securities | Neutral |
| 2023-07-25 | 再開されました | Jefferies | Buy |
| 2022-10-21 | 再開されました | Jefferies | Buy |
| 2022-07-29 | 開始されました | CapitalOne | Overweight |
| 2022-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 開始されました | Northland Capital | Outperform |
| 2019-03-13 | ダウングレード | Needham | Buy → Hold |
| 2019-03-13 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 繰り返されました | Needham | Buy |
| 2018-03-13 | 繰り返されました | Needham | Buy |
| 2017-12-01 | 繰り返されました | Needham | Buy |
| 2017-11-09 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 繰り返されました | Needham | Buy |
| 2017-03-14 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 繰り返されました | Needham | Buy |
| 2016-05-10 | 繰り返されました | Needham | Buy |
| 2016-02-19 | 開始されました | Wells Fargo | Outperform |
| 2015-06-19 | 繰り返されました | Needham | Buy |
| 2015-06-03 | 開始されました | Raymond James | Strong Buy |
| 2014-07-21 | 開始されました | Needham | Buy |
すべてを表示
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com
U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com
JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat
Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa
Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Australia
Portolan Capital Management LLC Cuts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance
Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World
Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com
Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Renaissance Group LLC Has $3.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month LowShould You Sell? - MarketBeat
Needham & Company LLC Reiterates Hold Rating for Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Dynamic Technology Lab Private Ltd Acquires 14,468 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Glucagon Market Set to Witness Significant Growth by 2032 | Eli - openPR.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Increased by Vanguard Group Inc. - Defense World
Trexquant Investment LP Buys 16,248 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar at Needham Conference: Strategic Growth Amidst Challenges By Investing.com - Investing.com Canada
Amphastar stock hits 52-week low at $25.72 amid market challenges - Investing.com Australia
Amphastar stock hits 52-week low at $25.72 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 500 Shares of Stock - MarketBeat
KLP Kapitalforvaltning AS Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 3.1%Should You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by American Century Companies Inc. - MarketBeat
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021 - ACCESS Newswire
We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Can Stay On Top Of Its Debt - simplywall.st
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 - ACCESS Newswire
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference - ACCESS Newswire
Amphastar Leadership Team Set for Major Investor Presentation at Needham Conference - Stock Titan
Amphastar Pharmaceuticals director sells $14,190 in stock - Investing.com India
Amphastar Pharmaceuticals director sells $14,190 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022 - ACCESS Newswire
Amphastar Pharmaceuticals Inc (AMPH) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
大文字化:
|
ボリューム (24 時間):